Amerika Serikat - Inggris - NLM (National Library of Medicine)

seroyal usa - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av) - arsenic trioxide 6 [hp_x] - indications for the temporary relief of symptoms associated with flu and indigestion indications for the temporary relief of symptoms associated with flu and indigestion directions adults: take five granules three times daily or as recommended by your healthcare practitioner. children: take three granules and follow adult directions.

Amerika Serikat - Inggris - NLM (National Library of Medicine)

natural creations, inc. - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), cadmium sulfate (unii: 947unf3z6o) (cadmium cation - unii:t494fz4g8g), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), human breast tumor cell (unii: c62oo7vd9k) (human breast tumor cell - unii:c62oo7vd9k), conium maculatum flowering top (unii: q28r5gf371) (conium maculatum flowering top - unii:q28r5gf371), lycopodium clavatum spore (unii: c88x29y479) (lycopo - arsenic cation (3+) 30 [hp_c] in 1 ml - uses: temporarily relieves exhaustion, glandular swellings, weakness, icy coldness, trembling, congestion, sleeplessness, &/or other symptoms associated with loss of vitality. uses: temporarily relieves exhaustion, glandular swellings, weakness, icy coldness, trembling, congestion, sleeplessness, &/or other symptoms associated with loss of vitality.

Amerika Serikat - Inggris - NLM (National Library of Medicine)

cephalon, inc. - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av) - arsenic trioxide 1 mg in 1 ml - trisenox is indicated in combination with tretinoin for treatment of adults with newly-diagnosed low-risk acute promyelocytic leukemia (apl) whose apl is characterized by the presence of the t(15;17) translocation or pml/rar-alpha gene expression. trisenox is indicated for induction of remission and consolidation in patients with apl who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterized by the presence of the t(15;17) translocation or pml/rar-alpha gene expression. trisenox is contraindicated in patients who are hypersensitive to arsenic. risk summary based on the mechanism of action [see clinical pharmacology (12.1)] and findings in animal studies, trisenox can cause fetal harm when administered to a pregnant woman. arsenic trioxide was embryolethal and teratogenic in rats when administered on gestation day 9 at a dose approximately 10 times the recommended human daily dose on a mg/m² basis (see data) . a related trivalent arsenic, sodium arsen

Amerika Serikat - Inggris - NLM (National Library of Medicine)

cephalon, llc - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av) - arsenic trioxide 2 mg in 1 ml - trisenox is indicated in combination with tretinoin for treatment of adults with newly-diagnosed low-risk acute promyelocytic leukemia (apl) whose apl is characterized by the presence of the t(15;17) translocation or pml/rar-alpha gene expression. trisenox is indicated for induction of remission and consolidation in patients with apl who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterized by the presence of the t(15;17) translocation or pml/rar-alpha gene expression. trisenox is contraindicated in patients with hypersensitivity to arsenic. risk summary based on the mechanism of action [see clinical pharmacology (12.1)] and findings in animal studies, trisenox can cause fetal harm when administered to a pregnant woman. arsenic trioxide was embryolethal and teratogenic in rats when administered on gestation day 9 at a dose approximately 10 times the recommended human daily dose on a mg/m2  basis (see data) . a related trivalent arsenic, sodium arsen

Amerika Serikat - Inggris - NLM (National Library of Medicine)

trp company - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), histamine dihydrochloride (unii: 3poa0q644u) (histamine - unii:820484n8i3), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), magnesium phosphate, dibasic trihydrate (unii: hf539g9l3q) (magnesium cation - unii:t6v3lhy838), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), aspidosperma quebracho-blanco bark (unii: 52b1340190) (aspidosperma quebracho-blanco bark - unii:52b1340190), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - arsenic trioxide 6 [hp_c] - according to homeopathic indications, these ingredients provide temporary relief of asthma and copd like symptoms such as: • difficulty breathing • inflammation in the airways • coughing • wheezing • shortness of breath • sensation of tightness of the chest • congestion after a diagnosis of asthma or copd by a physician.

Amerika Serikat - Inggris - NLM (National Library of Medicine)

white manufacturing inc. dba micro west - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), echinacea, unspecified (unii: 4n9p6cc1dx) (echinacea, unspecified - unii:4n9p6cc1dx), gelsemium sempervirens root (unii: 639kr60q1q) (gelsemium sempervirens root - unii:639kr60q1q), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), lycopodium clavatum spore (unii: c88x29y479) (lycopodium clavatum spore - unii:c88x29y479), atropa belladonna (unii: wqz3g9pf0h) (atropa belladonna - unii: - arsenic trioxide 12 [hp_x] in 30 ml - for the temporary relief of heaviness, weakness, weariness, numbness, tingling, muscle soreness or aching indications : for the temporary relief of heaviness, weakness, weariness, numbness, tingling, muscle soreness or aching

Amerika Serikat - Inggris - NLM (National Library of Medicine)

zydus lifesciences limited - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av) - arsenic trioxide injection is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (apl) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterized by the presence of the t(15;17) translocation or pml/rar-alpha gene expression. arsenic trioxide is contraindicated in patients who are hypersensitive to arsenic. risk summary based on the mechanism of action [see clinical pharmacology (12.1)] and findings in animal studies, arsenic trioxide can cause fetal harm when administered to a pregnant woman. arsenic trioxide was embryolethal and teratogenic in rats when administered on gestation day 9 at a dose approximately 10 times the recommended human daily dose on a mg/m2 basis (see data) . a related trivalent arsenic, sodium arsenite, produced teratogenicity when administered during gestation in mice at a dose approximately 5 times the projected human dose on a mg/m2 basis and in hamsters at an intravenous d

Amerika Serikat - Inggris - NLM (National Library of Medicine)

sti pharma llc - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av) - arsenic trioxide injection is indicated for induction of remission and consolidation in patients with apl who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterized by the presence of the t(15;17) translocation or pml/rar-alpha gene expression. arsenic trioxide for injection is contraindicated in patients who are hypersensitive to arsenic. risk summary based on the mechanism of action [see clinical pharmacology ( 12.1) ] and findings in animal studies, arsenic trioxide injection can cause fetal harm when administered to a pregnant woman. arsenic trioxide was embryolethal and teratogenic in rats when administered on gestation day 9 at a dose approximately 10 times the recommended human daily dose on a mg/m 2 basis ( see data ). a related trivalent arsenic, sodium arsenite, produced teratogenicity when

Amerika Serikat - Inggris - NLM (National Library of Medicine)

zydus lifesciences limited - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av) - arsenic trioxide injection is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (apl) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterized by the presence of the t(15;17) translocation or pml/rar-alpha gene expression. arsenic trioxide is contraindicated in patients who are hypersensitive to arsenic. risk summary based on the mechanism of action [see clinical pharmacology (12.1)] and findings in animal studies, arsenic trioxide can cause fetal harm when administered to a pregnant woman. arsenic trioxide was embryolethal and teratogenic in rats when administered on gestation day 9 at a dose approximately 10 times the recommended human daily dose on a mg/m2 basis (see data) . a related trivalent arsenic, sodium arsenite, produced teratogenicity when administered during gestation in mice at a dose approximately 5 times the projected human dose on a mg/m2 basis and in hamsters at an intravenous d

Amerika Serikat - Inggris - NLM (National Library of Medicine)

sagent pharmaceuticals - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av) - arsenic trioxide injection is indicated for induction of remission and consolidation in patients with apl who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterized by the presence of the t(15;17) translocation or pml/rar-alpha gene expression. arsenic trioxide is contraindicated in patients with hypersensitivity to arsenic. risk summary based on the mechanism of action [see clinical pharmacology (12.1)] and findings in animal studies, arsenic trioxide can cause fetal harm when administered to a pregnant woman. arsenic trioxide was embryolethal and teratogenic in rats when administered on gestation day 9 at a dose approximately 10 times the recommended human daily dose on a mg/m² basis (see data ). a related trivalent arsenic, sodium arsenite, produced teratogenicity when administered during gestation in mice at a dose approximately 5 times the projected human dose on a mg/m² basis and in hamsters at an intravenous dose approximately equivalent to th